Squarepoint’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-28,189
| Closed | -$1.05M | – | 2970 |
|
|
2023
Q1 | $1.05M | Sell |
28,189
-4,301
| -13% | -$160K | ﹤0.01% | 1140 |
|
|
2022
Q4 | $1.47M | Buy |
+32,490
| New | +$1.47M | 0.01% | 919 |
|
|
2022
Q3 | – | Sell |
-72,722
| Closed | -$4.88M | – | 2653 |
|
|
2022
Q2 | $4.88M | Buy |
72,722
+66,382
| +1,047% | +$4.46M | 0.03% | 435 |
|
|
2022
Q1 | $521K | Buy |
+6,340
| New | +$521K | ﹤0.01% | 1470 |
|
|
2021
Q4 | – | Sell |
-1,801
| Closed | -$319K | – | 2911 |
|
|
2021
Q3 | $319K | Sell |
1,801
-8,529
| -83% | -$1.51M | ﹤0.01% | 1608 |
|
|
2021
Q2 | $1.67M | Buy |
+10,330
| New | +$1.67M | 0.01% | 902 |
|
|
2021
Q1 | – | Sell |
-5,058
| Closed | -$1.11M | – | 3173 |
|
|
2020
Q4 | $1.11M | Buy |
+5,058
| New | +$1.11M | 0.01% | 1024 |
|
|
2020
Q1 | – | Sell |
-10,879
| Closed | -$1.4M | – | 2594 |
|
|
2019
Q4 | $1.4M | Buy |
+10,879
| New | +$1.4M | 0.01% | 1098 |
|
|
2019
Q3 | – | Sell |
-10,100
| Closed | -$1.04M | – | 2623 |
|
|
2019
Q2 | $1.04M | Sell |
10,100
-72,824
| -88% | -$7.5M | 0.01% | 1225 |
|
|
2019
Q1 | $6.08M | Buy |
82,924
+56,545
| +214% | +$4.14M | 0.06% | 372 |
|
|
2018
Q4 | $1.12M | Buy |
+26,379
| New | +$1.12M | 0.01% | 868 |
|
|
2018
Q2 | – | Sell |
-14,200
| Closed | -$436K | – | 2120 |
|
|
2018
Q1 | $436K | Buy |
+14,200
| New | +$436K | 0.01% | 1138 |
|
|
2017
Q4 | – | Sell |
-20,975
| Closed | -$245K | – | 2386 |
|
|
2017
Q3 | $245K | Buy |
+20,975
| New | +$245K | ﹤0.01% | 1267 |
|